<DOC>
	<DOCNO>NCT02062307</DOCNO>
	<brief_summary>The aim study investigate marker bone mineral metabolism unconfounded group patient hypogonadism search relationship endothelial dysfunction insulin resistance .</brief_summary>
	<brief_title>Bone Mineral Markers Hypogonadism</brief_title>
	<detailed_description>Cardiometabolic disorder prevalent patient hypogonadism . Endothelial dysfunction insulin resistance use determine cardiovascular risk . The role marker bone mineral metabolism hypogonadism clearly present . 49 male patient hypogonadotropic hypogonadism ( HH ) 43 BMI age match healthy male subject enrol . Osteoprotegerin ( OPG ) , fibroblast growth factor-23 ( FGF-23 ) , vitamin D asymmetric dimethylarginine ( ADMA ) level measure . The insulin sensitivity estimate homeostatic model assessment-insulin resistance ( HOMA-IR ) formula .</detailed_description>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<criteria>male patient hypogonadotropic hypogonadism age 45 age 18 previously give testosterone human chorionic gonadotropin therapy chronic metabolic disorder organ dysfunction female patient Other reason hipogondism receive treatment hypogonadism presence comorbid disease</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Hypogonadism</keyword>
	<keyword>Asymmetric Dimethyl Arginine</keyword>
	<keyword>Osteoprotegerin</keyword>
	<keyword>Fibroblast Growth Factor</keyword>
	<keyword>Vitamin D</keyword>
</DOC>